Your browser doesn't support javascript.
loading
Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics.
Boger, Dale L; Miyauchi, Hiroshi; Du, Wu; Hardouin, Christophe; Fecik, Robert A; Cheng, Heng; Hwang, Inkyu; Hedrick, Michael P; Leung, Donmienne; Acevedo, Orlando; Guimarães, Cristiano R W; Jorgensen, William L; Cravatt, Benjamin F.
Afiliación
  • Boger DL; Department of Chemistry, Cell Biology, and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA. boger@scripps.edu
J Med Chem ; 48(6): 1849-56, 2005 Mar 24.
Article en En | MEDLINE | ID: mdl-15771430
ABSTRACT
Fatty acid amide hydrolase (FAAH) degrades neuromodulating fatty acid amides including anandamide (endogenous cannabinoid agonist) and oleamide (sleep-inducing lipid) at their sites of action and is intimately involved in their regulation. Herein we report the discovery of a potent, selective, and efficacious class of reversible FAAH inhibitors that produce analgesia in animal models validating a new therapeutic target for pain intervention. Key to the useful inhibitor discovery was the routine implementation of a proteomics-wide selectivity screen against the serine hydrolase superfamily ensuring selectivity for FAAH coupled with systematic in vivo examinations of candidate inhibitors.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oxazoles / Piridinas / Amidohidrolasas / Analgésicos / Cetonas Límite: Animals / Humans Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2005 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oxazoles / Piridinas / Amidohidrolasas / Analgésicos / Cetonas Límite: Animals / Humans Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2005 Tipo del documento: Article País de afiliación: Estados Unidos